Research | More on Jose L. Lopez-Ribot
Jose L. Lopez-Ribot, Pharm.D./Ph.D.
Department of Biology,
University of Texas San Antonio
(UTHSCSA, School of Medicine, Microbiology & Immunology)
Tel: (210) 458-7022
Fax: (210) 458-7023
Dr. Lopez-Ribot has over 25 years of educational and research experience in the field of Microbiology and more specifically, Medical Mycology. He leads the graduate educational component of the DoD0funded "Center of Excellence in Infection Genomics," with the overall goal of increasing the number of graduates, including underrepresented minorities, the the fields of molecular Microbiology & Immunology. He also serves as mentor/preceptor in the MBRS/RISE and MARC-USTAR graduate and undergraduate research programs to increase the number of underrepresented students int he biomedical sciences. He has served as chair of the Doctoral Studies Committee of the Cellular and Molecular Biology Ph.D. program. Most recently he developed the new Molecular Microbiology and Immunology track within the PhD program in Cell and Molecular Biology, and also contributed to the development of the new BS degree in Microbiology and Immunology at the University of Texas San Antonio as well as the PhD program in Translational Medicine, established jointy between Immunology at UTSA and UTHSCSA. During his academic career Dr. Lopez-Ribot has served as a mentor for over 25 graduate students, postdoctoral fellows, and visiting scientists. He has also served in over 75 thesis dissertation and graduate exam committees.
Ph.D., Pharmacy/Microbiology at the University of Valencia, Valencia, Spain
Keywords: Candida albicans
Dr. Lopez-Ribot's lab studies the immunopathogenesis of fungal infections, with an emphasis on the opportunistic pathogenic fungus Candida albicans. Some of the highlights of this research program include: a) development of novel immune-based therapies to combat candidiasis, b) the role of morphogenetic conversions in the pathogenesis of candidiasis, c) the study of C. albicans biofilms, and d) and high throughput screening for antifungal drug discovery. Other areas of interest include genomics and proteomics, cell wall and adhesion, antifungal drug resistance and development of diagnostic techniques for candidiasis. The main projects in the lab currently deal with targeting virulence factors, more specifically filamentation and biofilm formation, for the development of novel antifungal agents, and with developing microbial chips as a new universal technology platform for microbial culture at the nanoscale level
Complete List of Publications